![Second- and third-line treatment strategies in multiple myeloma: a referral-center experience | Blood Cancer Journal Second- and third-line treatment strategies in multiple myeloma: a referral-center experience | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00757-8/MediaObjects/41408_2022_757_Figa_HTML.png)
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience | Blood Cancer Journal
![Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma](https://pbs.twimg.com/media/FjuuMEaWYAIZrC8.jpg)
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma
![Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma](https://pbs.twimg.com/media/FBqsJXhVEAQt4p4.jpg)
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma
![Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020 Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020](https://www.mdpi.com/cancers/cancers-12-02885/article_deploy/html/images/cancers-12-02885-g001-550.jpg)
Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
![Suggested treatment options for newly diagnosed multiple myeloma (MM)... | Download Scientific Diagram Suggested treatment options for newly diagnosed multiple myeloma (MM)... | Download Scientific Diagram](https://www.researchgate.net/publication/347277088/figure/fig1/AS:11431281210530803@1702051129341/Suggested-treatment-options-for-newly-diagnosed-multiple-myeloma-MM-patients_Q320.jpg)
Suggested treatment options for newly diagnosed multiple myeloma (MM)... | Download Scientific Diagram
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies | Haematologica
Suggested treatment options for newly diagnosed multiple myeloma (MM)... | Download Scientific Diagram
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
![PLEIADES study design. a Assessed using next-generation sequencing. CR,... | Download Scientific Diagram PLEIADES study design. a Assessed using next-generation sequencing. CR,... | Download Scientific Diagram](https://www.researchgate.net/publication/343338285/figure/fig1/AS:933700225204224@1599622889659/PLEIADES-study-design-a-Assessed-using-next-generation-sequencing-CR-complete.png)
PLEIADES study design. a Assessed using next-generation sequencing. CR,... | Download Scientific Diagram
![A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma - ScienceDirect A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121047029-gr1.jpg)
A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma - ScienceDirect
![The Evolving Clinical and Pharmacoeconomic Impact of Isatuximab in Multiple Myeloma Management | Value-Based Cancer Care The Evolving Clinical and Pharmacoeconomic Impact of Isatuximab in Multiple Myeloma Management | Value-Based Cancer Care](https://www.valuebasedcancer.com/images/Tables-Figures/2022/TLG2331/TLG2331-figure-5.jpg)
The Evolving Clinical and Pharmacoeconomic Impact of Isatuximab in Multiple Myeloma Management | Value-Based Cancer Care
![Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond | Leukemia Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2017.329/MediaObjects/41375_2018_Article_BFleu2017329_Fig3_HTML.jpg)
Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond | Leukemia
![Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis | Advances in Therapy Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-020-01521-9/MediaObjects/12325_2020_1521_Fig1_HTML.png)
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis | Advances in Therapy
![Cancers | Free Full-Text | Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice Cancers | Free Full-Text | Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice](https://pub.mdpi-res.com/cancers/cancers-15-02160/article_deploy/html/images/cancers-15-02160-g002.png?1681114532)